Tykerb (lapatinib)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Tykerb (lapatinib), covering 2011-10-19 to 2017-06-02. Get the full timeline:
Most recent: Clinical Trial Update: Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial Metastases [Phase 2]